CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Accordingly, ESRD patients are particularly susceptible to COVID-19 infection. Ta1 has been shown to be safely administered to hemo...
Phase 2
Kansas City, Missouri, United States of America
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...
Phase 2
Kansas City, Kansas, United States and 6 other locations
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...
Phase 2
Kansas City, Kansas, United States and 6 other locations
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Kansas City, Missouri, United States and 217 other locations
This is an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 g...
Phase 1
Kansas City, Missouri, United States of America and 16 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Fairway, Kansas, United States and 59 other locations
The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...
Phase 3
Kansas City, Missouri, United States of America and 159 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Kansas City, Missouri, United States and 214 other locations
against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine, MV-014-212, is a li...
Phase 1
Lenexa, Kentucky, United States of America and 1 other location
for teenagers. The booster targets a particular variant of COVID-19, Omicron XBB.1.5. The main focus is on safety: researchers want-...
Phase 3
Lenexa, Kansas, United States and 19 other locations
Clinical trials
Research sites
Resources
Legal